Clinical Trials in Texas

Showing 12121-12140 of 15,101 trials

Identification and Semi -Quantification of ER/PR Proteins Expression

NCT02654431

The purpose of the study is the identification and quantification of proteins expression level in breast cancer tissues. The imaging system is intended for diagnostic use as an aid to the pathologist in the detection, counting and classifying ER/PR IHC stained samples.

Breast Cancer

Applied Spectral Imaging Ltd.350 participantsStarted May 2013

Temple, Texas, United States

COMPLETEDPhase 213 miles

S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin

NCT00234039

RATIONALE: Drugs used in chemotherapy, such as gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving gemcitabine directly into the bladder may kill more tumor cells. PURPOSE: This phase II trial is studying how well gemcitabine works in treating patients with recurrent bladder cancer that has progressed despite previous Bacillus Calmette-Guerin (BCG).

Bladder Cancer

SWOG Cancer Research Network58 participantsStarted Nov 2006

Little Rock, Arkansas, United States • Los Angeles, California, United States • Leesburg, Florida, United States +95 more locations

Identification and Semi -Quantification of ER/PR Proteins Expression

S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin

Find Trials by Condition in Texas

Safety and Tolerability of Glatiramer Acetate

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1

Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe Disease

Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation

Feasibility Study of BMAC Enhanced CABG

Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer

The Study of Soy Isoflavones in Asthma

Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters

Understanding Sleep Problems in Children With Autism Spectrum Disorder

A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy

Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis

A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia

Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer

Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer

Safety, Pharmacokinetics, and Pharmacodynamics of NBI-98854 in Children and Adolescents With Tourette Syndrome

Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer

Tolerance of Healthy Infants Fed Infant Formulas